Peptide record

TPDB04391

Antibacterial Antifungal standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB04391
Antibacterial Antifungal
Anti-infective peptides
AntiBP3 Peptipedia Antifungipept
standard
No
A 23-aa standard-residue multi-activity (Antibacterial and Antifungal) peptide sequence curated from AntiBP3, Peptipedia, and Antifungipept, with an available 3D structural model.
Sequence
FLTGVLKLASKIPSVLCAVLKTC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C111H194N26O28S2
RNDEQHMWY
L
2405.04
9.80
3
0
12
+3
-1.01
1.339
148.26
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
6
Residue Composition
number
2
A
0
R
0
N
0
D
2
C
0
E
0
Q
1
G
0
H
1
I
5
L
3
K
0
M
1
F
1
P
2
S
2
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 5 K: 3 M: 0 F: 1 P: 1 S: 2 T: 2 W: 0 Y: 0 V: 3
Chemical Descriptors
23 reviewed residue count
C111H194N26O28S2 sequence-only estimate (linear, free termini)
2405.04 sequence-only estimate (linear, free termini)
9.80 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-1.01 sequence-only estimate (linear, free termini)
1.339 sequence-only estimate (linear, free termini)
Evidence Records 6 records
Evidence 1 Activity

Activity

MIC
Antibacterial
19 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

NA

Other

inst Gram+ bacteria E.faecium 091299 (IS) (MIC 150 uM), E. faecalis 981 (IS) (MIC 19 uM), S. aureus ATCC25923 (MIC 19 uM), S. carnosus KHS (IS) (MIC 37.5 uM), B. licheniformis X39 (IS) (MIC 37.5 uM), R. rhodochr
Evidence 2 Activity

Activity

MIC
Antibacterial
>150 µM

Target

E.coli ATCC25922

Source & Reference

NA

Other

uM), B. licheniformis X39 (IS) (MIC 37.5 uM), R. rhodochrous X15 (IS)(MIC 4.8 uM), Gram- E.coli ATCC25922 (MIC >150 uM), S.typhi 091408 (IS)(MIC >150 uM), P.aeruginosa (ATCC27853) (MIC >150 uM), P.aeruginosa (
Evidence 3 Activity

Activity

MIC
Antibacterial
>150 µM

Target

C.albicans ATCC10231

Source & Reference

NA

Other

M), P.aeruginosa (ATCC27853) (MIC >150 uM), P. faecalis X29 (IS) (MIC 37.5 uM), and fungi C.albicans ATCC10231 (MIC>150 uM).
Evidence 4 Activity

Activity

MIC
Antifungal
19 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

Antifungipept

Other

inst Gram+ bacteria E.faecium 091299 (IS) (MIC 150 uM), E. faecalis 981 (IS) (MIC 19 uM), S. aureus ATCC25923 (MIC 19 uM), S. carnosus KHS (IS) (MIC 37.5 uM), B. licheniformis X39 (IS) (MIC 37.5 uM), R. rhodochr
Evidence 5 Activity

Activity

MIC
Antifungal
>150 µM

Target

E.coli ATCC25922

Source & Reference

Antifungipept

Other

uM), B. licheniformis X39 (IS) (MIC 37.5 uM), R. rhodochrous X15 (IS)(MIC 4.8 uM), Gram- E.coli ATCC25922 (MIC >150 uM), S.typhi 091408 (IS)(MIC >150 uM), P.aeruginosa (ATCC27853) (MIC >150 uM), P.aeruginosa (
Evidence 6 Activity

Activity

MIC
Antifungal
>150 µM

Target

C.albicans ATCC10231

Source & Reference

Antifungipept

Other

M), P.aeruginosa (ATCC27853) (MIC >150 uM), P. faecalis X29 (IS) (MIC 37.5 uM), and fungi C.albicans ATCC10231 (MIC>150 uM).